Home › Down Syndrome › New York › New York City
Down Syndrome clinical trials in New York City, NY
3 studies for Down Syndrome are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- and 1 more
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
RecruitingPhase 2
- Icahn School of Medicine at Mount Sinai, New York
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
RecruitingObservational study
- Carnegie Imaging for Women, New York
About Down Syndrome
About 1 in 700 babies are born with the birth defect known as Down Syndrome. Learn about the different Down Syndrome types and related health issues.
More about Down Syndrome on MedlinePlus
Down Syndrome trials in other cities
- Aurora, CO7 studies
- Phoenix, AZ6 studies
- Durham, NC6 studies
- Houston, TX6 studies
- Philadelphia, PA5 studies
- Cincinnati, OH5 studies
- St. Louis, MO5 studies
- Ann Arbor, MI5 studies
- Nashville, TN5 studies
- Cleveland, OH5 studies
- Orlando, FL5 studies
- San Diego, CA4 studies
Other studies in New York City
- Breast Cancer144 studies
- Non-Small Cell Lung Cancer123 studies
- Cancer (all types)105 studies
- Prostate Cancer101 studies
- Metastatic Cancer93 studies
- Colorectal Cancer86 studies
- Ovarian Cancer75 studies
- Lung Cancer60 studies
- Multiple Myeloma59 studies
- Pancreatic Cancer57 studies
- Endometrial Cancer54 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.